𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differentiation between infection and rejection in the management of cardiac transplant patients

✍ Scribed by Paul C. McGovern; Emily A. Blumberg

Book ID
107542127
Publisher
Springer
Year
2001
Tongue
English
Weight
187 KB
Volume
3
Category
Article
ISSN
1523-3847

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Association between enterovirus endomyoc
Association between enterovirus endomyocardial infection and late severe cardiac events in some adult patients receiving heart transplants
✍ Fatima Douche-Aourik; Thomas Bourlet; Jean-FranΓ§ois Mosnier; JΓ©rΓ΄me Jacques; Chr πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

## Abstract Enteroviruses and other cardiotropic viruses have been associated with the development of late severe adverse cardiac events in infants receiving heart transplants. However, the source and the chronology of cardiac allograft infection by an enterovirus in patients receiving heart transp

Characteristics of photopheresis treatme
Characteristics of photopheresis treatments for the management of rejection in heart and lung transplant recipients
✍ Hanh M. Khuu; Renee Desmond; Shu T. Huang; Marisa B. Marques πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

## Abstract Photopheresis has been used in the management of rejection of heart and/or lung transplants. Although its mechanism of action remains unknown, irradiated T‐helper cell‐induced immunosuppression is the main theory. Since transplant recipients are often lymphopenic and lymphocytes are the

Management of drug-to-drug interactions
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients
✍ Martin Vogel; Esther Voigt; Hans-Christoph Michaelis; Thomas Sudhop; Martin Wolf πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 1 views

Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi